Otamixaban Is Promising New Treatment For Patients With Acute Coronary Syndromes (SEPIA-ACS1 TIMI 42 Study)
Links shared publicly online about this topic.
- 1,775total visits
Otamixaban Is Promising New Treatment For Patients With Acute Coronary Syndromes (SEPIA-ACS1 TIMI 42 Study)
An article published online first and in an upcoming edition of the lancet shows that otamixaban is a promising new agent for patients with acute coronary syndromes (heart attacks or sudden
View full resource at medicalnewstoday.com
Tags: Heart, Heart Disease, Heart Attack, Thrombotic Event, Disease and Condition
Most Recently Shared on September 4, 2009 at 4:09 am By:
Otamixaban Is Promising New Treatment For Patients With Acute Coronary Syndromes (SEPIA-ACS1 TIMI 42 Study): An .. http://bit.ly/13sy0x
Also Shared By:
Otamixaban May Be A Useful Alternative Treatment For Patients With Acute Coronary Syndromes (SEPIA-ACS1 TIMI 42 Study)
medicalnewstoday.com — “An article published online first and in a future edition of the lancet reports that otamixaban is a potential new agent for patients with acute coronary syndromes, such as heart attacks or” View full resource at medicalnewstoday.com
Most Recently Shared on September 2, 2009 at 10:12 am By:
Otamixaban May Be A Useful Alternative Treatment For Patients With Acute Coronary Syndromes (SEPIA-ACS1 TIMI 42 .. http://bit.ly/upORg
Advertisement
Heart Health
@HeartsHealth
MedicalNewsToday: Otamixaban Is Promising New Treatment For Patients With Acute Coronary: http://bit.ly/4h46l4 Full http://bit.ly/2RcQNh
1 year ago...